Nidda Healthcare GmbH
Nidda Healthcare GmbH
- Land: Deutschland
Nachricht vom 27.09.2017 | 16:52
Bain Capital and Cinven announce appointment of five new Supervisory Board members at STADA
DGAP-News: Nidda Healthcare Holding AG / Key word(s): Change of Personnel
Frankfurt / Munich, 27 September 2017 - Bain Capital and Cinven announce that the registry court in Frankfurt has appointed five new Supervisory Board members at STADA Arzneimittel AG ("STADA" or "the Group") effective today. The new members have replaced five former Supervisory Board members, including the Chairman, who resigned effective 25 September 2017.
Bain Capital and Cinven are pleased that Dr Günter von Au, the former Chief Executive Officer of Süd-Chemie AG, has joined the Supervisory Board of STADA. Dr von Au currently serves as Vice Chairman of the Board of Directors of Swiss chemicals group Clariant AG. He was CEO of Süd-Chemie AG from 2004 until 2012 and previously held leadership positions at Wacker Chemie AG for many years. In today's constitutive session of the Supervisory Board, Dr von Au was elected Chairman.
In addition, the court appointed representatives of the majority shareholders Bain Capital and Cinven to the Supervisory Board of STADA. Dr Michael Siefke, Managing Director in charge of Germany, and Benjamin Kunstler, Principal co-heading the European Healthcare sector team, will join the Supervisory Board on behalf of Bain Capital. Cinven will be represented by Bruno Schick, Partner and Head of Cinven Germany and Central Europe and Jan-Nicolas Garbe, Principal in the Healthcare sector team. Dr Eric Cornut as well as the employee representatives Jens Steegers (Deputy Chairman), Halil Duru and Dr Ute Pantke continue to serve on the Supervisory Board.
Michael Siefke and Bruno Schick said: "We are delighted that Dr von Au has agreed to join the Supervisory Board of STADA as its new Chairman. His eminent track record in senior leadership positions will be of great value for the company. Dr von Au is a widely recognised business leader who, together with the new management team, will foster a culture of positive momentum, collaboration and respect at STADA."
Dr Günter von Au, Chairman of the Supervisory Board of STADA, said: "I very much look forward to working together with the new management team and my colleagues on the Supervisory Board. STADA is set for a course of significant and very exciting change. I am determined to contribute significantly to support STADA's leadership team and its highly qualified employees in reaching the Group's ambitious strategic goals."
For Bain Capital
T +44 (0) 20 375 74 989
M +44 (0) 798 600 97 20
T +44 (0) 20 375 74 984
M +44 (0) 788 400 19 49
T +44 (0) 20 766 13325
M +44 (0) 7802 961 902
T +49 69 92037 110
M +49 173 651 7710
About Bain Capital Private Equity:
Bain Capital Private Equity has partnered closely with management teams to provide the strategic resources that build great companies and help them thrive since its founding in 1984. Bain Capital's global team of approximately 220 investment professionals creates value for its portfolio companies through its global platform and depth of expertise in key vertical industries including healthcare, consumer/retail, financial and business services, industrials, and technology, media and telecommunications. Bain Capital has offices in Boston, Chicago, New York, Palo Alto, San Francisco, Dublin, London, Luxembourg, Munich, Melbourne, Mumbai, Hong Kong, Shanghai, Sydney and Tokyo and has made investments in more than 300 companies to date. In addition to private equity, Bain Capital invests across asset classes including credit, public equity and venture capital, managing approximately USD 75 billion in total and leveraging the firm's shared platform to capture opportunities in strategic areas of focus.
For more information, visit www.baincapitalprivateequity.com
Cinven is a leading international private equity firm focused on building world-class European and global companies. Its funds invest in six key sectors: Healthcare, Business Services, Consumer, Financial Services, Industrials, and Technology, Media and Telecommunications (TMT). Cinven has offices in key locations including: Frankfurt, London, Paris, Milan, Madrid, Hong Kong, and New York. Since 1988, Cinven funds have invested in 120 companies worth around EUR90 billion. Today Cinven has more than EUR15 billion in assets under management. Cinven takes a responsible strategic approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society.
For more information, please visit www.cinven.com
Nidda Healthcare GmbH: Bain Capital and Cinven ...
Nidda Healthcare GmbH: Public delisting tender ...
Nidda Healthcare GmbH: Bain Capital Private Eq ...
Tender Offer; <DE0007251803>
Bain Capital and Cinven announce appointment o ...
GBC im Fokus
ISA gAG: Attraktive Wandelanleihe
Die International School Augsburg begibt Wandelanleihe als weiteren Finanzierungsbaustein des geplanten Schulneubaus; unserer Einschätzung nach liegen attraktive Konditionen vor und die Anleihe ist von der ISA gAG solide finanzierbar; das Wertpapier ist aus unserer Sicht sowohl für das Unternehmen als auch für die Investoren ein attraktives Investment.
Events im Fokus
12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie
Der AKTIONÄR News
08. August 07:44 Lufthansa: Weiter im Steigflug
08. August 07:47 Pfizer: Heiße Übernahmehgerüchte
08. August 07:55 Apple: Neue große Chancen
08. August 08:00 Thyssenkrupp vor Zahlen: Das müssen Trader jetzt beachten
08. August 08:29 BVB: Möglicher Haller-Ersatz ist eine echte Granate
Conference Call 15.08.2022 (Webcast)
15. August 2022
Original-Research: Landi Renzo S.p.A. (von GBC AG): Landi Renzo S.p.A.
08. August 2022